In a freshly released study of testing NMN in human, Samuel Klein’s team conducted double-blind clinical trial and found that NMN could improve insulin sensitivity, insulin signaling and muscle tissue remodeling in the prediabetic women with overweight or obesity (Yoshino et al., 2021). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.